Cargando…

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program

Detalles Bibliográficos
Autores principales:	Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959046/ https://www.ncbi.nlm.nih.gov/pubmed/27457763 http://dx.doi.org/10.1186/s12885-016-2559-8

Ejemplares similares

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBACCA) nested within a compassionate use program
por: Adenis, Antoine, et al.
Publicado: (2016)

Rebecca
por: Du Maurier, Daphne, 1907-
Publicado: (1962)

Rebecca
por: Du Maurier, Daphne, 1907-1989
Publicado: (1938)

Rebecca Gartner
por: Gartner, Rebecca
Publicado: (2022)

Rebecca Worthylake: The flooding of science
por: LeBrasseur, Nicole
Publicado: (2007)

First person – Rebecca Rolfe
Publicado: (2021)

Rebecca Heald: Passionate about cycles
por: Sedwick, Caitlin
Publicado: (2008)

“Understanding PAEDIATRIC ANAESTHESIA” by Dr. Rebecca Jacob
por: Grewal, Anju
Publicado: (2015)

REGOSARC: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis
por: Berry, Vincent, et al.
Publicado: (2017)

All About Mitochondrial Eve: An Interview with Rebecca Cann
por: Gitschier, Jane
Publicado: (2010)

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics
por: Sunakawa, Yu, et al.
Publicado: (2013)

Improving the quality of translation for patients with language barriers: Rebecca Newell
por: Newell, R, et al.
Publicado: (2022)

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
por: Brodowicz, Thomas, et al.
Publicado: (2015)

Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction: A case report: Erratum
Publicado: (2017)

Editorial – Global shortage of nurses – Rebecca Jester for May 2023 issue
por: Jester, Rebecca
Publicado: (2023)

Regorafenib: Adding to the Armamentarium for Refractory Colorectal Cancer and GIST
por: Roman, Danielle, et al.
Publicado: (2013)

Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer
por: Fogelman, David, et al.
Publicado: (2018)

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome
por: Adenis, Antoine, et al.
Publicado: (2013)

The Evolution and Functional Significance of Nested Gene Structures in Drosophila melanogaster
por: Lee, Yuh Chwen G., et al.
Publicado: (2013)

The Evolution and Functional Significance of Nested Gene Structures in Drosophila melanogaster
por: Lee, Yuh Chwen G., et al.
Publicado: (2013)

Mrs. Rebecca Strong (née Thorogood), O.B.E.: Pioneer in Nursing and Nursing Education
por: Patrick, John
Publicado: (1944)

Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice
por: Yoon, Sang Eun, et al.
Publicado: (2018)

Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer
por: Wong, Selina K., et al.
Publicado: (2019)

Erratum to: Education: The role of the first siderophore cephalosporin Fetcroja(®) (cefiderocol) in UK clinical practice: introduction; Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice; Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa; Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection; Education: An overview from the author of ‘Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients’
Publicado: (2021)

Towards shedding some light on regorafenib treatment in refractory metastatic colorectal cancer
por: Prager, Gerald, et al.
Publicado: (2017)

A meta-analysis of safety and efficacy of regorafenib for refractory metastatic colorectal cancer
por: Xue, Wu-Song, et al.
Publicado: (2018)

The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal Cancer
por: Yoon, Sang Eun, et al.
Publicado: (2019)

Regorafenib in Refractory Metastatic Colorectal Cancer: A Multi-Center Retrospective Study
por: Xu, Donghao, et al.
Publicado: (2022)

Erratum to: Education: The role of the first siderophore cephalosporin Fetcroja(®) (cefiderocol) in UK clinical practice: introduction; Antibiotic resistance during and beyond COVID-19; Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice; Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa; Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection; Education: An overview from the author of ‘Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients’
Publicado: (2021)

Erratum: Topological data analysis of contagion maps for examining spreading processes on networks
por: Taylor, Dane, et al.
Publicado: (2015)

Compassionate Counterterrorism
por: Olaimy, Leena
Publicado: (2019)

Compassionate Care
por: Post, Stephen G., et al.
Publicado: (2012)

Compassionate Conversations
por: Gardner, Sharryn, et al.
Publicado: (2014)

Erratum: Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection
por: Ribeiro-Viana, Renato, et al.
Publicado: (2013)

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
por: Hendlisz, Alain, et al.
Publicado: (2015)

Long-Term Regression after Discontinuation of Regorafenib Administered for Sorafenib-Refractory Hepatocellular Carcinoma
por: Bae, Heewon, et al.
Publicado: (2023)

Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials
por: Kotecki, Nuria, et al.
Publicado: (2012)

Cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access scheme
por: Harte, S., et al.
Publicado: (2022)

Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment
por: Pastor, Brice, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dbpr5t86m615p1a7e3ls8g6j38